findmyKOL

Howard Natter, MD

Basic profile

Allegheny College

ORCIDNone on fileNPI
RegionMeadowbrook, PA · NortheastSpecialtyNeurologyFocusNeurology
Active KOLfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication1999Online presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Howard Natter is a Neurology physician affiliated with Allegheny College. OpenAlex indexes 9 publications with 667 citations (h-index 7).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
9publications

Distinct works indexed by OpenAlex.

667citations

Total citations across indexed works.

7h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
52companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

1650 Huntingdon Pike
Suite 258
Meadowbrook, PA 190468004

Telephone

215-938-7730

Registry record last updated 6 Apr 2016.

View the NPPES registry record

Industry payments

52 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

View the CMS Open Payments record ↗

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Nervous system

    81.3%
    Other antiepileptics11.3%
    Levetiracetam53%Topiramate18%Lacosamide14%Xcopri6%Topamax5%Briviact2%Levetiracetam Er2%
    Part D<11 patients
    Gabapentinoids9.6%
    Gabapentin81%Pregabalin19%
    Part D91 patients

    + 31 more classes in this area

  • Musculoskeletal

    5.3%
    gamma-Aminobutyric Acid-ergic Agonist2.7%
    Baclofen100%
    Part D36 patients
    Central alpha-2 Adrenergic Agonist2.4%
    Tizanidine Hcl100%
    Part D32 patients

    + 1 more class in this area

  • Cancer & immunology

    4.8%
    Other immunosuppressants1.6%
    Dimethyl Fumarate63%Tecfidera37%
    Part D<11 patients
    Other immunostimulants1.4%
    Copaxone56%Glatiramer Acetate44%
    Part D<11 patients

    + 3 more classes in this area

Where care is delivered (Part B)0% facility · 100% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”